Inhibition of the ATR-CHK1 kinases, which activate cell cycle checkpoints in S and G2 in response to replication stress, was shown to enhance A3A-mediated toxicity in AML, lung, ovarian, and osteosarcoma cell lines [32,33]. The gene discussed is CHEK1; the disease is acute myeloid leukemia.